Literature DB >> 12351517

Epigenetic risks related to assisted reproductive technologies: risk analysis and epigenetic inheritance.

M De Rycke1, I Liebaers, A Van Steirteghem.   

Abstract

A broad spectrum of assisted reproductive technologies has become available for couples with fertility problems. Follow-up studies of children born as a result of assisted reproduction have shown that neonatal outcome and malformation rates are not different from those of the general population, except for a low birthweight and a slight increase in chromosomal abnormalities. The safety aspect of assisted reproduction at the epigenetic level has not been well studied. Epigenetics refers to phenomena where modifications of DNA methylation and/or chromatin structure underlie changes in gene expression and phenotype characteristics. This article intends to analyse epigenetic risks related to assisted reproduction on the basis of an overview of epigenetic reprogramming events in the gamete and early embryo. Two epigenetic modifications, methylation and imprinting, are considered in more detail. The interference of in-vitro embryo culture, immature sperm cells and nuclear transfer with epigenetic reprogramming is discussed, as well as the possibility of epigenetic inheritance.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12351517     DOI: 10.1093/humrep/17.10.2487

Source DB:  PubMed          Journal:  Hum Reprod        ISSN: 0268-1161            Impact factor:   6.918


  24 in total

1.  Evaluation of maturation competence of metaphase II oocytes in mice based on the distance between pericentriolar materials of meiotic spindle: distance of PCM during oocyte maturation.

Authors:  Chizuka Sakai; Yumi Hoshino; Yusuke Sato; Eimei Sato
Journal:  J Assist Reprod Genet       Date:  2010-11-17       Impact factor: 3.412

Review 2.  Developmental Programming, a Pathway to Disease.

Authors:  Vasantha Padmanabhan; Rodolfo C Cardoso; Muraly Puttabyatappa
Journal:  Endocrinology       Date:  2016-02-09       Impact factor: 4.736

3.  Epigenetic programming in the preimplantation rat embryo is disrupted by chronic paternal cyclophosphamide exposure.

Authors:  Tara S Barton; Bernard Robaire; Barbara F Hales
Journal:  Proc Natl Acad Sci U S A       Date:  2005-05-23       Impact factor: 11.205

4.  Reduced sperm DNA longevity is associated with an increased incidence of still born; evidence from a multi-ovulating sequential artificial insemination animal model.

Authors:  Stephen D Johnston; Carmen López-Fernández; Francisca Arroyo; Altea Gosálbez; Elva I Cortés Gutiérrez; Jose-Luis Fernández; Jaime Gosálvez
Journal:  J Assist Reprod Genet       Date:  2016-06-20       Impact factor: 3.412

5.  Methylation analysis of KvDMR1 in human oocytes.

Authors:  Elke Geuns; Pierre Hilven; André Van Steirteghem; Inge Liebaers; Martine De Rycke
Journal:  J Med Genet       Date:  2006-09-01       Impact factor: 6.318

Review 6.  Blastocyst environment and its influence on offspring cardiovascular health: the heart of the matter.

Authors:  Adam J Watkins; Tom P Fleming
Journal:  J Anat       Date:  2009-02-09       Impact factor: 2.610

7.  The risk of malformation following assisted reproduction.

Authors:  Hilke Bertelsmann; Helena de Carvalho Gomes; Monika Mund; Susanne Bauer; Katja Matthias
Journal:  Dtsch Arztebl Int       Date:  2008-01-07       Impact factor: 5.594

8.  Histone modifications and mRNA expression in the inner cell mass and trophectoderm of bovine blastocysts.

Authors:  Doris Herrmann; John Arne Dahl; Andrea Lucas-Hahn; Philippe Collas; Heiner Niemann
Journal:  Epigenetics       Date:  2013-02-13       Impact factor: 4.528

Review 9.  Imprinting disorders and assisted reproductive technology.

Authors:  Somjate Manipalviratn; Alan DeCherney; James Segars
Journal:  Fertil Steril       Date:  2009-02       Impact factor: 7.329

Review 10.  Epigenetics in the development, modification, and prevention of cardiovascular disease.

Authors:  Thomas F Whayne
Journal:  Mol Biol Rep       Date:  2014-09-10       Impact factor: 2.316

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.